Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Industrial Research Assistance Program – Contributions to Firms

PBD Biotech Canada Limited

$120,000.00

Development of the Actiphage technology for rapid and efficient diagnosis of mycobacterial infection in the Canadian setting

FY 2019-20 · 2019-12-01

Summary
PBD Bio has developed a substantially faster, more accurate and reliable method to detect the presence of live Mycobacterial infections. This project will validate the use of the technology in the Canadian setting and establish the base of Canadian operations.
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
Saskatoon|Saskatoon, Saskatchewan, Canada
Recipient Type
For-profit organization
Business Number
751747510
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

As published

Agreement End Date
2021-03-26
Agreement Number
939035
Agreement Start Date
2019-12-01
Agreement Title
Development of the Actiphage technology for rapid and efficient diagnosis of mycobacterial infection in the Canadian setting
Agreement Title (French)
Développement de la technologie Actiphage pour le diagnostic rapide et efficace des infections mycobactériennes dans le contexte canadien
Agreement Type
Contribution
Agreement Value
$120,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
PBD Bio has developed a substantially faster, more accurate and reliable method to detect the presence of live Mycobacterial infections. This project will validate the use of the technology in the Canadian setting and establish the base of Canadian operations.
Description (French)
PBD Bio a développé une méthode beaucoup plus rapide, précise et fiable pour détecter la présence d'infections mycobactériennes vivantes. Ce projet permettra de valider l'utilisation de la technologie dans le contexte canadien et d'établir la base des opérations canadiennes.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Saskatoon West
Federal Riding (French)
Saskatoon-Ouest
Federal Riding Number
47012
NAICS Code
62151
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
751747510
Recipient City
Saskatoon|Saskatoon
Recipient Country
CA
Recipient Legal Name
PBD Biotech Canada Limited
Recipient Postal Code
S7K 1M5
Recipient Province or Territory
SK
Recipient Type
F
Reference Number
172-2019-2020-Q4-939035